Last reviewed · How we verify
Oral cannabis low THC
At a glance
| Generic name | Oral cannabis low THC |
|---|---|
| Also known as | THC |
| Sponsor | Shanna Babalonis, PhD |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study Testing the Effects of Different THC Doses on Psychological and Biological Function (PHASE1)
- Age-dependent Effects of Smoked and Oral Delta-9-THC (PHASE1)
- The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment (PHASE1)
- Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment (PHASE1)
- Dose-Response Characterization of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain (PHASE2)
- Impact of Daily Oral Cannabis Doses in Patients With Cancer (PHASE1)
- The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles (PHASE1)
- Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |